Blueprint for Diabetic Sovereignty: Insulin Production from Concept to Reality (Vital Supply Lines) - Softcover

Inhaltsangabe

Take control of insulin. Take control of the future.

The U.S. insulin supply chain is vulnerable — dominated by three pharmaceutical giants and reliant on international components. In a post-COVID world where supply shocks and rising prices are the norm, millions of diabetics are left exposed. Blueprint for Diabetic Sovereignty offers a bold solution.

This book is the first of its kind: a practical, step-by-step guide to building a U.S.-based insulin production facility using American resources, talent, and infrastructure.

Written by a Type 1 diabetic with a background in business strategy and systems design, this book lays out everything an entrepreneur, investor, or health policy advocate needs to know to bring insulin production home — and put healthcare security into the hands of the people who need it most.

Inside this book, you'll discover:

• How to source all essential insulin components domestically
• A complete facility design and regulatory roadmap (including FDA and GMP compliance)
• Cost models, funding strategies, and site selection breakdowns
• Historical insights and future forecasts on the insulin market
• Why domestic insulin production isn’t just possible — it’s essential

Whether you’re a biotech visionary, a public health advocate, or a problem-solver looking to make real impact, this is more than a business manual — it’s a declaration of independence for American healthcare.

Because America's healthcare security should be made in America.
Part of the "Vital Supply Lines" series

Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.